AKT1 and ovarian cancer: Yang et al. demonstrated that tectorigenin acted synergistically with paclitaxel to induce apoptosis in drug-resistant ovarian cancer cells by inhibition of the AKT [a serine/threonine-specific protein kinase, also known as Protein kinase B (PKB)] pathway and downregulation of NFkB downstream targets [8].